How to use Asciminib

For patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+CML) chronic phase (CP) who have received two or more TKI treatments in the past The recommended dose of Asciminib is 80 mg taken orally once daily at about the same time each day, or 40 mg taken orally twice daily about 12 hours apart. Continue treatment withaceminias long as clinical benefit is observed or unacceptable toxicity occurs. For Ph+CML-CP patients with T315I mutation: The recommended dose of aximinib is 200 mg orally twice daily. The recommended dose of Asiminib is to be taken by mouth without eating. Avoid eating at least 2 hours before and at least 1 hour after taking Asiminib.